Fortress Biotech, Inc.

FBIO

Fortress Biotech, Inc.

FBIO

Insider Sentiment (TTM):

Last Purchase:2024-09-23Last Sale:2024-05-20Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,746,485Shares Outstanding:31,540,595Institutional Ownership Pct.:15.05%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Other Affiliates	-	1	0	-0	0	0	0	-0	-0	0	0	-0
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	197	256	79	86	74	91	57	59	76	84	81	72
Accounts Receivable Net Current	36	25	30	18	16	18	10	11	10	10	15	8
Inventory Net	8	9	10	12	13	12	14	12	10	11	10	11
Prepaid Expense And Other Assets Current	4	5	5	2	7	5	7	3	5	12	11	6
Assets Held For Sale Not Part Of Disposal Group Cu…	-	-	0	0	0	-	1	-	-	-	-	-
Assets Current	246	295	124	119	110	127	90	86	103	117	117	98
Property Plant And Equipment Net	2	2	3	3	3	3	3	3	4	6	7	7
Operating Lease Right Of Use Asset	11	12	12	12	13	13	14	14	15	16	17	18
Restricted Cash And Cash Equivalents Noncurrent	1	1	1	1	1	1	2	2	2	2	2	2
Equity Securities F V N I Noncurrent	29	19	18	-	-	-	3	-	-	-	-	-
Finite Lived Intangible Assets Net	26	26	28	29	30	31	32	18	19	19	20	21
Other Assets Noncurrent	1	1	0	18	3	3	1	3	3	4	4	5
Assets	317	357	186	181	160	178	144	127	146	165	168	151
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	49	93	47	45	49	66	66	64	69	76	74	81
Taxes Payable Current	5	5	0	1	1	1	1	1	1	1	1	0
Operating Lease Liability Current	2	2	2	2	2	2	3	3	2	3	3	2
Convertible Notes Payable Current	-	-	-	-	-	-	-	-	-	-	0	0
Other Liabilities Current	0	0	0	0	2	2	2	1	0	0	0	1
Liabilities Current	62	103	50	54	58	74	71	70	76	88	85	97
Long Term Notes Payable	35	37	52	48	50	56	58	52	67	61	61	46
Operating Lease Liability Noncurrent	11	12	13	13	13	14	15	15	16	18	18	19
Other Liabilities Noncurrent	3	2	1	2	2	2	2	2	2	2	2	2
Liabilities	111	155	123	116	123	146	146	140	160	169	166	164
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	788	786	784	786	780	774	764	755	739	733	717	702
Retained Earnings Accumulated Deficit	-624	-624	-734	-730	-736	-751	-741	-734	-721	-710	-695	-686
Stockholders Equity	206	202	62	56	37	32	23	-13	18	23	2	-13
Minority Interest	42	40	12	9	-7	10	-24	-34	-32	-27	-21	-30
Liabilities And Stockholders Equity	317	357	186	181	160	178	144	127	146	165	168	151
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	15	15	15	15	15	15	15	15	15	15	15	15
Preferred Stock Shares Issued	3	3	3	3	3	3	3	3	3	3	3	3
Preferred Stock Shares Outstanding	3	3	3	3	3	3	3	3	3	3	3	3
Preferred Stock Liquidation Preference	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	33	33	31	31	30	30	28	28	23	19	15	9
Shares Outstanding	33	33	31	31	30	30	28	28	23	19	15	9

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	15.22%	32.17%	43.04%	-	-	-	-	-	-	-	-	-
2025	12.36%	5.62%	1.69%	89.29%	40.31%	30.61%	8.02%	53.82%	18.32%	-16.49%	-1.79%	7.17%
2024	3.45%	3.45%	9.77%	-3.28%	-10.93%	3.83%	30.57%	42.04%	15.92%	5.13%	14.10%	14.10%
2023	-	-	-	-27.78%	-38.89%	-72.35%	136.36%	83.33%	40.15%	-12.50%	-3.50%	-6.50%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.96	2.86	2.49	2.19	1.92	1.72	1.27	1.23	1.37	1.33	1.38	1.00
Quick Ratio	3.76	2.72	2.20	1.93	1.57	1.49	0.96	1.02	1.18	1.07	1.13	0.83
Working Capital	183.49M	192.09M	74.10M	64.44M	52.88M	53.23M	18.97M	15.97M	27.89M	28.85M	32.11M	475.00K
Leverage & Debt
Debt to Equity	0.54	0.76	1.98	2.08	3.28	4.48	-88.73	-10.98	8.97	7.32	104.56	-12.37
Debt Ratio	0.35	0.43	0.66	0.64	0.77	0.82	1.01	1.10	1.10	1.02	0.99	1.09
Efficiency & Turnover
Asset Turnover TTM	0.28	0.24	0.37	0.37	0.36	0.32	0.35	0.42	0.36	0.28	0.26	0.25
Days Sales Outstanding TTM	141.66	122.63	119.25	90.48	86.01	91.92	84.25	58.95	84.98	112.81	132.85	110.49
Receivables Turnover TTM	2.58	2.98	3.06	4.03	4.24	3.97	4.33	6.19	4.30	3.24	2.75	3.30
Per Share Metrics
Diluted EPS TTM	4.25	3.85	-0.07	-1.57	-2.55	-4.47	-5.81	-7.92	-8.08	-8.51	-19.01	-19.83
Free Cash Flow Per Share TTM	3.96	5.00	-2.36	-2.98	-3.54	-3.43	-4.65	-5.26	-5.48	-6.44	-15.82	-18.84
Dividend Per Share TTM	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.04	0.04	0.04	0.09	0.10
Margin Metrics
Gross Profit Margin TTM	64.76%	65.09%	65.83%	65.11%	65.92%	64.40%	62.13%	68.07%	65.07%	62.92%	61.63%	52.98%
Operating Profit Margin TTM	-43.64%	-86.91%	-114.67%	-154.92%	-189.21%	-174.01%	-200.20%	-183.59%	-167.28%	-198.33%	-238.58%	-294.01%
Net Profit Margin TTM	202.30%	231.17%	-3.07%	-90.16%	-137.14%	-213.88%	-219.20%	-269.89%	-253.22%	-241.26%	-258.38%	-246.46%
Growth Metrics
Net Revenue Growth (1Y)	20.68%	15.89%	11.07%	0.04%	-5.18%	-8.73%	-7.59%	-4.24%	-4.37%	-2.95%	-15.96%	-16.90%
Net Income Growth (1Y)	-278.01%	-225.26%	-98.44%	-66.58%	-48.64%	-19.09%	-21.60%	4.87%	-24.01%	-34.13%	-27.94%	-36.35%
EPS Growth (1Y)	-250.51%	-205.04%	-98.84%	-75.84%	-65.00%	-47.53%	-69.41%	-60.08%	-69.40%	-73.92%	-47.36%	-49.40%
Valuation Metrics
P/E TTM	0.72	0.59	-54.26	-1.93	-0.66	-0.35	-0.35	-0.18	-0.21	-0.23	-0.16	-0.22
P/B TTM	0.47	0.43	1.64	1.80	1.34	1.27	-25.66	-2.24	1.75	1.49	15.38	-2.46
P/S TTM	1.46	1.37	1.67	1.74	0.90	0.75	0.77	0.49	0.54	0.57	0.41	0.54
Market Cap	97.28M	88.00M	102.12M	100.80M	50.00M	41.26M	42.19M	28.56M	31.32M	34.30M	24.41M	32.62M
Enterprise Value	-65.91M	-132.18M	73.94M	61.14M	24.42M	5.09M	41.34M	20.12M	20.06M	9.89M	1.90M	3.67M
Calculated Values
Free Cash Flow TTM	125.92M	157.64M	-65.78M	-81.14M	-95.09M	-90.76M	-96.59M	-103.64M	-100.36M	-110.46M	-128.29M	-141.26M
Net Debt	-163.19M	-220.18M	-28.18M	-39.66M	-25.58M	-36.18M	-853.00K	-8.44M	-11.26M	-24.42M	-22.51M	-28.95M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-09-23Purchase

Owner: Rosenwald, Lindsay A Md

Title: PRESIDENT, CEO & CHAIRMAN

Shares: 763,359

Price/Share: $1.84

Value: $1,404,580.56

Shares Owned: 3,657,264

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2024-07-11Purchase

Owner: Rosenwald, Lindsay A Md

Title: President, CEO & Chairman

Shares: 5,000

Price/Share: $7.48

Value: $37,400.00

Shares Owned: 127,500

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2024-07-10Purchase

Owner: Jin, David

Title: Chief Financial Officer

Shares: 500

Price/Share: $7.50

Value: $3,750.00

Shares Owned: 500

Relationship: Officer

Ownership: Direct

2024-07-09Purchase

Owner: Rosenwald, Lindsay A Md

Title: President, CEO & Chairman

Shares: 5,000

Price/Share: $7.39

Value: $36,950.00

Shares Owned: 122,500

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2024-07-08Purchase

Owner: Rosenwald, Lindsay A Md

Title: President, CEO & Chairman

Shares: 5,000

Price/Share: $7.35

Value: $36,750.00

Shares Owned: 117,500

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-09-23	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	PRESIDENT, CEO & CHAIRMAN	Direct	Purchase	763,359	1.84	$1,404,580.56	3,657,264	4
2024-07-11	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	President, CEO & Chairman	Direct	Purchase	5,000	7.48	$37,400.00	127,500	4
2024-07-10	Jin, David	Officer	Chief Financial Officer	Direct	Purchase	500	7.50	$3,750.00	500	4
2024-07-09	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	President, CEO & Chairman	Direct	Purchase	5,000	7.39	$36,950.00	122,500	4
2024-07-08	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	President, CEO & Chairman	Direct	Purchase	5,000	7.35	$36,750.00	117,500	4
2024-06-28	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	President, CEO & Chairman	Direct	Purchase	20,000	1.64	$32,800.00	2,893,905	4
2024-05-20	Klein, Dov	Director	-	Direct	Sale	10,000	1.89	$18,900.00	53,400	4
2024-05-16	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	President, CEO & Chairman	Direct	Purchase	10,000	1.76	$17,600.00	2,873,905	4
2024-01-05	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	President, CEO & Chairman	Direct	Purchase	50,000	2.38	$119,000.00	2,863,905	4
2023-11-14	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	President, CEO & Chairman	Direct	Purchase	1,567,515	1.70	$2,664,775.50	2,597,440	4
2023-11-14	Weiss, Michael S	Director,Officer	See Remarks	Direct	Purchase	147,058	1.70	$249,998.60	1,130,520	4
2023-09-26	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	President, CEO & Chairman	Direct	Purchase	100,000	0.28	$28,000.00	15,449,091	4
2023-08-18	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	President, CEO & Chairman	Direct	Purchase	10,000	9.34	$93,400.00	112,500	4
2023-02-10	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	President, CEO & Chairman	Direct	Purchase	2,395,209	0.84	$2,011,975.56	15,349,091	4
2023-02-10	Lu, Lucy	Director	-	Direct	Purchase	11,976	0.84	$10,059.84	133,379	4
2023-02-10	Jin, David	Officer	Chief Financial Officer	Direct	Purchase	35,928	0.84	$30,179.52	1,438,757	4
2023-02-10	Rowinsky, Eric K	Director	-	Direct	Purchase	11,976	0.84	$10,059.84	931,976	4
2023-02-10	Lobell, J Jay	Director	-	Direct	Purchase	299,401	0.84	$251,496.84	1,635,401	4
2023-02-10	Weiss, Michael S	Director,Officer,TenPercentOwner	See Remarks	Direct	Purchase	1,197,604	0.84	$1,005,987.36	14,752,034	4
2022-12-01	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	PRESIDENT, CEO & CHAIRMAN	Direct	Purchase	100,000	0.68	$68,000.00	11,730,324	4
2022-11-30	Jin, David	Officer	Chief Financial Officer	Direct	Purchase	5,000	0.56	$2,800.00	1,402,829	4
2022-11-30	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	PRESIDENT, CEO & CHAIRMAN	Direct	Purchase	5,000	0.56	$2,800.00	11,630,324	4
2022-10-21	Rosenwald, Lindsay A Md	Director,Officer,TenPercentOwner	PRESIDENT, CEO & CHAIRMAN	Direct	Purchase	100,000	0.70	$70,000.00	11,625,324	4
2021-12-28	Klein, Dov	Director	-	Direct	Sale	5,000	2.45	$12,250.00	651,015	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

15.05%

Inst. Shares: 4,746,485

Shares Outstanding: 31,540,595

2025-12-31

19.60%

Inst. Shares: 5,467,866

Shares Outstanding: 27,901,889

2025-09-30

14.58%

Inst. Shares: 3,971,972

Shares Outstanding: 27,244,474

2025-06-30

15.86%

Inst. Shares: 4,263,072

Shares Outstanding: 26,879,380

2025-03-31

11.48%

Inst. Shares: 3,036,721

Shares Outstanding: 26,450,218

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,746,485	31,540,595	15.05%
2025-12-31	5,467,866	27,901,889	19.60%
2025-09-30	3,971,972	27,244,474	14.58%
2025-06-30	4,263,072	26,879,380	15.86%
2025-03-31	3,036,721	26,450,218	11.48%
2024-12-31	3,325,691	20,784,334	16.00%
2024-09-30	3,032,234	19,697,290	15.39%
2024-06-30	2,775,595	18,316,874	15.15%
2024-03-31	2,216,803	17,151,945	12.92%
2023-12-31	4,072,605	8,110,906	50.21%
2023-09-30	18,455,801	7,498,653	246.12%
2023-06-30	20,174,699	7,377,332	273.47%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Fortress Biotech, Inc. (FBIO) — SEC Financial Statements & Analysis

Fortress Biotech, Inc. (FBIO) is a pharmaceutical preparations company, incorporated in DE. Fortress Biotech, Inc. trades on Nasdaq as: FBIO, FBIOP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Fortress Biotech, Inc. reported a 20.68% year-over-year revenue growth, a Gross Profit Margin of 64.76% (TTM), a Debt-to-Equity ratio of 0.54x, a Price-to-Sales (P/S) ratio of 1.46x (TTM), a Price-to-Book (P/B) ratio of 0.47x (TTM), at a market cap of $97.28M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 20.68%
Gross Profit Margin TTM: 64.76%
Debt To Equity: 0.54x
P/S TTM: 1.46x
P/B TTM: 0.47x
Market Cap: $97.28M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Fortress Biotech, Inc. in?

Fortress Biotech, Inc. (FBIO) operates in the Pharmaceutical Preparations industry.

What is FBIO's market cap?

Fortress Biotech, Inc. (FBIO) has a market capitalization of $97.28M as of 2026-06-30.

What is FBIO's P/E ratio?

Fortress Biotech, Inc. (FBIO)'s trailing twelve month P/E ratio is 0.72x as of 2026-06-30.

What exchange does FBIO trade on?

Fortress Biotech, Inc. (FBIO) trades on the Nasdaq.

Where is Fortress Biotech, Inc. incorporated?

Fortress Biotech, Inc. is incorporated in DE.